Vaccines, Peptide

Known as: Peptide Vaccine, Peptide Vaccines 
A vaccine based on a synthetic peptide or peptides produced from tissue samples or recombinant sources. Vaccination with peptide vaccines may elicit… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
The immune system influences the fate of developing cancers by not only functioning as a tumour promoter that facilitates… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
PURPOSE Nivolumab, a human immunoglobulin G4-blocking antibody against the T-cell programmed death-1 checkpoint protein, has… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND An improvement in overall survival among patients with metastatic melanoma has been an elusive goal. In this phase 3… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The Wilms' tumor gene WT1 is overexpressed in leukemias and various types of solid tumors, and the WT1 protein was demonstrated… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2001
Highly Cited
2001
CD4 T-cell help is required during the generation and maintenance of effective antitumor CD8 T cell-mediated immunity. The goal… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
The outcome of antigen recognition by naive CD8+ cytotoxic T lymphocytes (CTLs) in the periphery is orchestrated by CD4+ T-helper… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1999
Highly Cited
1999
HER-2/neu is a "self" tumor antigen that is overexpressed in 15-30% of human adenocarcinomas. Vaccine strategies directed against… (More)
  • figure 1
  • figure 2
  • table 2
  • table 1
  • figure 3
Is this relevant?
Highly Cited
1998
Highly Cited
1998
The cloning of the genes encoding cancer antigens has opened new possibilities for the treatment of patients with cancer. In this… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
The BALB/c Meth A sarcoma carries a p53 missense mutation at codon 234, which occurs in a peptide, termed 234CM, capable of being… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1995
Highly Cited
1995
The identification of antigenic peptides presented on the tumor cell surface by HLA class I molecules and recognized by tumor… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?